Skip to main content
. 2020 May 5;127(6):875–879. doi: 10.1007/s00702-020-02168-0

Table 2.

Total (< 75 years and ≥ 75 years) tolerability rates and mean dose for prolonged release dopamine agonists

PPX-PR ROP-XL RTG
Tolerability (total group) 94.1% 92.3% 84.4%
Mean dose total group 2.9 mg 12.5 mg 8.4 mg
Mean dose (< 75 years) 3.2 mg 13.7 mg 8.8 mg
Mean dose (≥ 75 years) 2.3 mg 9.2 mg 7.8 mg

PPX-PR pramipexole prolonged release, ROP-XL ropinirole extended release, RTG rotigotine